Lunit, a software company devoted to developing AI solutions for precision diagnostics and treatment support, mainly focused on conquering cancer, priced its IPO of 1,215,800 shares at KRW30,000 per share, below the KRW44,000–49,000 range to raise KRW36.5bn (US$23m). Pricing was finalised at a discount of 31.8% lower than the bottom of the target range. “The…
Home Healthcare Markets International Business South Korea: Lunit prices IPO below target range to raise KRW36.5bn